Orchid Ventures Secures Exclusive Global License for CELLg8®, a Patented and Clinically Proven Delivery System for C
IRVINE, CA / ACCESSWIRE / April 2, 2020 / ORCHID VENTURES, INC. (CSE:ORCD)(OTCPINK:ORVRF) (the “Company” or “Orchid”), a multi-state cannabis company, is pleased to announce that Orchid, through a wholly owned subsidiary, has entered into a licensing agreement, dated March 31, 2020 (the “Licensing Agreement”) with two privately held nutrient delivery system companies. The Licensing […]
